Simplex Trading
CSBR icon

Simplex Trading’s Champions Oncology CSBR Stock Holding History

Simplex Trading’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800
Closed -$5K – 9199
2025
Q2 		$5K Sell
800
-100
-11% -$706 ﹤0.01% 7718
2025
Q1 		$7K Hold
900
– – ﹤0.01% 7305
2024
Q4 		$7K Buy
+900
New +$4.53K ﹤0.01% 7402
2023
Q3 		– Sell
-2,800
Closed -$17K – 8809
2023
Q2 		$17K Buy
2,800
+1,800
+180% +$9.29K ﹤0.01% 6923
2023
Q1 		$4K Buy
+1,000
New +$4.27K ﹤0.01% 8152
2022
Q4 		– Sell
-1,100
Closed -$8K – 9358
2022
Q3 		$8K Hold
1,100
– – ﹤0.01% 8390
2022
Q2 		$8K Buy
+1,100
New +$8.41K ﹤0.01% 8451

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Simplex Trading's CSBR Position: Q4 2024 in Review

Simplex Trading sold out of Champions Oncology (CSBR) in Q4 2024, closing a stake of 113 shares — an estimated $569 sold.

Simplex Trading first reported a position in CSBR in Q2 2022 and held it in 6 quarters. The position peaked at $15K in Q2 2024. 25 funds tracked by Wall St. Rank hold CSBR as of Q4 2024.

  • Simplex Trading reported no remaining Champions Oncology position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 113 Champions Oncology shares in Q4 2024, an estimated $569.
  • Simplex Trading first reported a position in Champions Oncology in Q2 2022 and held it in 6 quarters.
  • Simplex Trading's Champions Oncology position peaked at $15K in Q2 2024.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.